Serum Lipid Levels in Patients with Eating Disorders

Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Pr...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 55; no. 14; pp. 1853 - 1857
Main Authors Nakai, Yoshikatsu, Teramukai, Satoshi, Fukusima, Mitsuo, Taniguchi, Ataru, Noma, Shun'ichi
Format Journal Article
LanguageEnglish
Published Japan The Japanese Society of Internal Medicine 01.01.2016
Subjects
Online AccessGet full text
ISSN0918-2918
1349-7235
1349-7235
DOI10.2169/internalmedicine.55.5632

Cover

Abstract Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.
AbstractList Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.
Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as greater than or equal to 120 mg/dL and the non-HDL cholesterol risk as greater than or equal to 150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.
Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a large Japanese cohort of different groups of feeding and eating disorders, according to the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012 (JAS Guidelines 2012). Methods Participants in the current study included 732 women divided into four groups of feeding and eating disorders: anorexia nervosa, restricting type (AN-R); anorexia nervosa, binge-eating/purging type; bulimia nervosa (BN); and binge-eating disorder (BED). We measured the serum levels of total cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride in these participants. Low-density-lipoprotein (LDL) cholesterol and non-HDL cholesterol levels were also calculated. Results The concentrations of LDL cholesterol and non-HDL cholesterol were widely distributed in all groups. When the LDL cholesterol risk was defined as ≥120 mg/dL and the non-HDL cholesterol risk as ≥150 mg/dL, according to the JAS Guidelines 2012, the proportion of LDL cholesterol risk ranged from 29.6% (BN) to 38.6% (AN-R), and the proportion of non-HDL cholesterol risk ranged from 17.8% (BN) to 30.1% (BED). Conclusion The present findings suggest the existence of LDL cholesterol risk and non-HDL cholesterol risk in all groups of eating disorders. Given the chronicity of this condition, the development of elevated concentrations of LDL cholesterol and non-HDL cholesterol at an early age may increase the risk of cardiovascular diseases.
Author Noma, Shun'ichi
Teramukai, Satoshi
Nakai, Yoshikatsu
Fukusima, Mitsuo
Taniguchi, Ataru
Author_xml – sequence: 1
  fullname: Nakai, Yoshikatsu
  organization: Kyoto Institute of Health Sciences, Japan
– sequence: 1
  fullname: Teramukai, Satoshi
  organization: Department of Biostatistics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Japan
– sequence: 1
  fullname: Fukusima, Mitsuo
  organization: Division of Clinical Nutrition and Internal Medicine, Okayama Prefectural University, Japan
– sequence: 1
  fullname: Taniguchi, Ataru
  organization: Kyoto Preventive Medical Center, Japan
– sequence: 1
  fullname: Noma, Shun'ichi
  organization: Department of Psychiatry, School of Medicine, Kyoto University, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27432092$$D View this record in MEDLINE/PubMed
BookMark eNqNkMtKxDAUhoMozkVfQbp00zHXpt0IouMFCgrqOqTpqRNp0zHJKL691eosxIWbczjw_f-Bb4Z2Xe8AoYTgBSVZcWJdBO9020FtjXWwEGIhMkZ30JQwXqSSMrGLprggeUqHMUGzEJ4xZrks6D6aUMkZxQWdIn4PftMlpV3bOinhFdqQWJfc6WjBxZC82bhKlsPlnpILG3pfgw8HaK_RbYDD7z1Hj5fLh_PrtLy9ujk_K1OTYR5TSgEEEZnBVVVpmesGGC4kE5wTKUhd8IpKWkvQjakN1ZjzmjU4k7XBJKsqNkfHY-_a9y8bCFF1NhhoW-2g3wRFciYZ45Tgf6BYyIxhwgf06BvdVINAtfa20_5d_UgZgHwEjO9D8NBsEYLVp3_1278SQn36H6Knv6LGxsFe76LXtv1Pwe1Y8ByifoLtZ-2jNS38GST8Kz42bEmz0l6BYx8CGq9W
CitedBy_id crossref_primary_10_1007_s10286_021_00836_z
crossref_primary_10_12873_451valbuena
crossref_primary_10_3390_nu12082331
crossref_primary_10_1016_j_physbeh_2024_114777
crossref_primary_10_3390_nu10121887
crossref_primary_10_1002_eat_24072
crossref_primary_10_1590_1518_8345_2567_3040
crossref_primary_10_3389_fnins_2021_682208
crossref_primary_10_1038_s41380_019_0573_3
crossref_primary_10_1016_j_jacl_2022_09_006
crossref_primary_10_1002_nbm_4469
crossref_primary_10_1007_s40519_023_01567_y
crossref_primary_10_1002_erv_2833
crossref_primary_10_3390_ijms231810814
crossref_primary_10_1016_j_chc_2019_05_009
Cites_doi 10.1210/jcem-38-2-325
10.1037/t07827-000
10.1002/1098-108X(199404)15:3<293::AID-EAT2260150315>3.0.CO;2-U
10.1079/BJN20041151
10.1001/jama.285.19.2486
10.1002/(SICI)1098-108X(199903)25:2<187::AID-EAT8>3.0.CO;2-9
10.1016/0167-5273(94)90270-4
10.1093/clinchem/18.6.499
10.1176/appi.books.9780890425596
10.1002/eat.20298
10.1016/j.psychres.2014.05.018
10.1097/01.crd.0000216745.96062.7c
10.1038/oby.2008.600
10.1002/(SICI)1098-108X(199805)23:4<425::AID-EAT10>3.0.CO;2-V
10.1007/s11739-014-1107-2
10.1507/endocrj1954.35.455
10.1016/j.physbeh.2011.08.014
10.1210/jcem-25-11-1520
10.1002/erv.2203
10.1016/0026-0495(78)90125-7
10.1016/j.jacl.2013.11.001
10.1097/01.yco.0000228759.95237.78
10.1002/eat.1087
10.1002/erv.2290
10.1016/j.psychres.2004.06.019
10.1002/eat.22389
10.1002/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W
10.1001/jama.2012.366
ContentType Journal Article
Copyright 2016 by The Japanese Society of Internal Medicine
Copyright_xml – notice: 2016 by The Japanese Society of Internal Medicine
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
DOI 10.2169/internalmedicine.55.5632
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-7235
EndPage 1857
ExternalDocumentID 27432092
10_2169_internalmedicine_55_5632
article_internalmedicine_55_14_55_55_5632_article_char_en
Genre Journal Article
GroupedDBID ---
29J
2WC
5GY
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
HYE
JSF
JSH
OK1
OVT
P2P
PGMZT
RJT
RNS
RPM
RZJ
TR2
XSB
.55
3O-
53G
AAYXX
CITATION
EMOBN
M48
TKC
X7M
7.U
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
7T5
H94
ID FETCH-LOGICAL-c604t-22ee5156c0bbba78afe309735441751d94b272d7eafcdc2a044d3f067dc016bb3
ISSN 0918-2918
1349-7235
IngestDate Fri Jul 11 07:51:45 EDT 2025
Fri Jul 11 09:16:34 EDT 2025
Thu Jan 02 22:31:25 EST 2025
Tue Jul 01 01:40:02 EDT 2025
Thu Apr 24 23:05:06 EDT 2025
Wed Sep 03 06:29:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c604t-22ee5156c0bbba78afe309735441751d94b272d7eafcdc2a044d3f067dc016bb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/internalmedicine/55/14/55_55.5632/_article/-char/en
PMID 27432092
PQID 1805763014
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1837334210
proquest_miscellaneous_1805763014
pubmed_primary_27432092
crossref_primary_10_2169_internalmedicine_55_5632
crossref_citationtrail_10_2169_internalmedicine_55_5632
jstage_primary_article_internalmedicine_55_14_55_55_5632_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-01-01
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Internal Medicine
PublicationTitleAlternate Intern. Med.
PublicationYear 2016
Publisher The Japanese Society of Internal Medicine
Publisher_xml – name: The Japanese Society of Internal Medicine
References 30. Kilgore M, Muntner P, Woolley JM, Sharma P, Bittner V, Rosenson RS. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. J Clin Lipidol 8: 86-93, 2014.
2. Nakai Y, Nin K, Noma S. Eating disorder symptoms among Japanese female students in 1982, 1992 and 2002. Psychiatr Res 219: 151-156, 2014.
9. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2012. Japan Atherosclerosis Society, Tokyo, Japan, 2012 (in Japanese).
28. Roehrig M, Masheb RM, White MA, Grillo CM. Dieting frequency in obese patients with binge eating disorder: Behavioral and metabolic correlates. Obesity 17: 689-697, 2009.
1. Nakai Y, Nin K, Noma S. Epidemiological data on eating disorders in Japan. In: New Developments in Anorexia Nervosa Research. Gramaglia C, Zeppegno P, Eds. Nova Science Publishers, INC, New York, 2014: 173-187.
19. Mordasini R, Klose G, Greten H. Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism 27: 71-79, 1978.
12. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders - Patient edition (SCID/P). In: Biometrics Research Department. New York State Psychiatric Institute, New York, 1995.
22. Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 25: 187-193, 1999.
11. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 39: 598-601, 2006.
17. Klinefelter HF. Hypercholesterolemia in anorexia nervosa. J Clin Endocrinol 25: 1520-1521, 1965.
5. Nakai Y, Nin K, Noma S, Hamagaki S, Takagi R, Wonderlich SA. Outcome of eating disorders in a Japanese sample: A 4- to 9-year follow-up study. Eur Eat Disord Rev 22: 206-211, 2014.
25. Pauporte J, Walsh BT. Serum cholesterol in bulimia nervosa. Int J Eat Disord 30: 294-298, 2001.
10. Bannai C, Kuzuya N, Koide Y, et al. Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455-462, 1988.
18. Nestel PJ. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. J Clin Endocrinol Metab 38: 325-328, 1974.
23. Vize CM, Coker S. Hypercholesterolemia in bulimia nervosa. Int J Eat Disord 15: 293-295, 1994.
21. Weinbrenner T, Zuger M, Jacoby GE, et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholestrolaemia. Br J Nutr 9: 959-969, 2004.
29. Carnier J, Sanches PL, da Silva PL, et al. Obese adolescents with eating disorders: analysis of metabolic and inflammatory status. Psychol Behav 105: 175-180, 2012.
4. Di Cola G, Jacoangeli F, Jacoangeli F, Lombardo M, Iellamo F. Cardiovascular disorders in anorexia nervosa and potential therapeutic targets. Intern Emerg Med 9: 717-721, 2014.
16. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2002. Japan Atherosclerosis Society, Tokyo, Japan, 2002 (in Japanese).
31. Garcia-Rubira JC, Hidalgo R, Gomez-Barrado JJ, Romero D, Cruz Fernandez JM. Anorexia nervosa and myocardial infarction. Int J Cardiol 45: 138-140, 1994.
8. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 307: 1302-1309, 2012.
13. Nakai Y, Fukushima M, Taniguchi A, Nin K, Teramukai S. Comparison of DSM-IV versus proposed DSM-5 diagnostic criteria for eating disorders in a Japanese sample. Eur Eat Disorders Rev 21: 8-14, 2012.
6. Casiero D, Frishman WH. Cardiovascular complications of eating disorders. Cardiol Rev 14: 227-231, 2006.
7. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19: 389-394, 2006.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, 2013.
24. Sullivan PF, Gendall KA, Bulik CM, Carter FA, Joyce PR. Elevated total cholesterol in bulimia nervosa. Int J Eat Disord 23: 425-432, 1998.
15. Friedewald WT. Estimation of the concentration of LDL cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
27. Mitchell JE, King WC, Pories W, et al. Binge eating disorder and medical comorbidities in bariatric surgery candidates. Int J Eat Disord 48: 471-476, 2015.
20. Mehler PS, Lezotte D, Eckel R. Lipid levels in anorexia nervosa. Int J Eat Disord 24: 217-221, 1998.
26. Monteleone P, Santonastaso P, Pannuto M, et al. Enhanced serum cholesterol and TG levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 134: 267-273, 2005.
22
23
24
25
26
27
28
29
(7) 2001; 285
30
31
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
8
9
20
21
References_xml – reference: 20. Mehler PS, Lezotte D, Eckel R. Lipid levels in anorexia nervosa. Int J Eat Disord 24: 217-221, 1998.
– reference: 1. Nakai Y, Nin K, Noma S. Epidemiological data on eating disorders in Japan. In: New Developments in Anorexia Nervosa Research. Gramaglia C, Zeppegno P, Eds. Nova Science Publishers, INC, New York, 2014: 173-187.
– reference: 8. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 307: 1302-1309, 2012.
– reference: 23. Vize CM, Coker S. Hypercholesterolemia in bulimia nervosa. Int J Eat Disord 15: 293-295, 1994.
– reference: 17. Klinefelter HF. Hypercholesterolemia in anorexia nervosa. J Clin Endocrinol 25: 1520-1521, 1965.
– reference: 2. Nakai Y, Nin K, Noma S. Eating disorder symptoms among Japanese female students in 1982, 1992 and 2002. Psychiatr Res 219: 151-156, 2014.
– reference: 9. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2012. Japan Atherosclerosis Society, Tokyo, Japan, 2012 (in Japanese).
– reference: 13. Nakai Y, Fukushima M, Taniguchi A, Nin K, Teramukai S. Comparison of DSM-IV versus proposed DSM-5 diagnostic criteria for eating disorders in a Japanese sample. Eur Eat Disorders Rev 21: 8-14, 2012.
– reference: 12. First M, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders - Patient edition (SCID/P). In: Biometrics Research Department. New York State Psychiatric Institute, New York, 1995.
– reference: 4. Di Cola G, Jacoangeli F, Jacoangeli F, Lombardo M, Iellamo F. Cardiovascular disorders in anorexia nervosa and potential therapeutic targets. Intern Emerg Med 9: 717-721, 2014.
– reference: 25. Pauporte J, Walsh BT. Serum cholesterol in bulimia nervosa. Int J Eat Disord 30: 294-298, 2001.
– reference: 29. Carnier J, Sanches PL, da Silva PL, et al. Obese adolescents with eating disorders: analysis of metabolic and inflammatory status. Psychol Behav 105: 175-180, 2012.
– reference: 14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, 2013.
– reference: 19. Mordasini R, Klose G, Greten H. Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism 27: 71-79, 1978.
– reference: 7. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
– reference: 11. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 39: 598-601, 2006.
– reference: 5. Nakai Y, Nin K, Noma S, Hamagaki S, Takagi R, Wonderlich SA. Outcome of eating disorders in a Japanese sample: A 4- to 9-year follow-up study. Eur Eat Disord Rev 22: 206-211, 2014.
– reference: 24. Sullivan PF, Gendall KA, Bulik CM, Carter FA, Joyce PR. Elevated total cholesterol in bulimia nervosa. Int J Eat Disord 23: 425-432, 1998.
– reference: 3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19: 389-394, 2006.
– reference: 30. Kilgore M, Muntner P, Woolley JM, Sharma P, Bittner V, Rosenson RS. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. J Clin Lipidol 8: 86-93, 2014.
– reference: 18. Nestel PJ. Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. J Clin Endocrinol Metab 38: 325-328, 1974.
– reference: 28. Roehrig M, Masheb RM, White MA, Grillo CM. Dieting frequency in obese patients with binge eating disorder: Behavioral and metabolic correlates. Obesity 17: 689-697, 2009.
– reference: 31. Garcia-Rubira JC, Hidalgo R, Gomez-Barrado JJ, Romero D, Cruz Fernandez JM. Anorexia nervosa and myocardial infarction. Int J Cardiol 45: 138-140, 1994.
– reference: 16. Japan Atherosclerosis Society. Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerosis Cardiovascular Diseases 2002. Japan Atherosclerosis Society, Tokyo, Japan, 2002 (in Japanese).
– reference: 26. Monteleone P, Santonastaso P, Pannuto M, et al. Enhanced serum cholesterol and TG levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables. Psychiatry Res 134: 267-273, 2005.
– reference: 6. Casiero D, Frishman WH. Cardiovascular complications of eating disorders. Cardiol Rev 14: 227-231, 2006.
– reference: 22. Case T, Lemieux S, Kennedy SH, Lewis GF. Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 25: 187-193, 1999.
– reference: 27. Mitchell JE, King WC, Pories W, et al. Binge eating disorder and medical comorbidities in bariatric surgery candidates. Int J Eat Disord 48: 471-476, 2015.
– reference: 15. Friedewald WT. Estimation of the concentration of LDL cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
– reference: 21. Weinbrenner T, Zuger M, Jacoby GE, et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholestrolaemia. Br J Nutr 9: 959-969, 2004.
– reference: 10. Bannai C, Kuzuya N, Koide Y, et al. Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455-462, 1988.
– ident: 18
  doi: 10.1210/jcem-38-2-325
– ident: 12
  doi: 10.1037/t07827-000
– ident: 23
  doi: 10.1002/1098-108X(199404)15:3<293::AID-EAT2260150315>3.0.CO;2-U
– ident: 21
  doi: 10.1079/BJN20041151
– volume: 285
  start-page: 2486
  issn: 0098-7484
  year: 2001
  ident: 7
  publication-title: JAMA The Journal of the American Medical Association
  doi: 10.1001/jama.285.19.2486
– ident: 16
– ident: 22
  doi: 10.1002/(SICI)1098-108X(199903)25:2<187::AID-EAT8>3.0.CO;2-9
– ident: 31
  doi: 10.1016/0167-5273(94)90270-4
– ident: 15
  doi: 10.1093/clinchem/18.6.499
– ident: 14
  doi: 10.1176/appi.books.9780890425596
– ident: 11
  doi: 10.1002/eat.20298
– ident: 9
– ident: 2
  doi: 10.1016/j.psychres.2014.05.018
– ident: 6
  doi: 10.1097/01.crd.0000216745.96062.7c
– ident: 28
  doi: 10.1038/oby.2008.600
– ident: 24
  doi: 10.1002/(SICI)1098-108X(199805)23:4<425::AID-EAT10>3.0.CO;2-V
– ident: 1
– ident: 4
  doi: 10.1007/s11739-014-1107-2
– ident: 10
  doi: 10.1507/endocrj1954.35.455
– ident: 29
  doi: 10.1016/j.physbeh.2011.08.014
– ident: 17
  doi: 10.1210/jcem-25-11-1520
– ident: 13
  doi: 10.1002/erv.2203
– ident: 19
  doi: 10.1016/0026-0495(78)90125-7
– ident: 30
  doi: 10.1016/j.jacl.2013.11.001
– ident: 3
  doi: 10.1097/01.yco.0000228759.95237.78
– ident: 25
  doi: 10.1002/eat.1087
– ident: 5
  doi: 10.1002/erv.2290
– ident: 26
  doi: 10.1016/j.psychres.2004.06.019
– ident: 27
  doi: 10.1002/eat.22389
– ident: 20
  doi: 10.1002/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W
– ident: 8
  doi: 10.1001/jama.2012.366
SSID ssj0038792
Score 2.1819277
Snippet Objective To evaluate some risk factors for cardiovascular diseases in feeding and eating disorders, the degree of lipid abnormalities was investigated in a...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1853
SubjectTerms Adolescent
Adult
Anorexia Nervosa - blood
Bulimia - blood
Bulimia Nervosa - blood
Cardiovascular Diseases - blood
Cardiovascular Diseases - epidemiology
eating disorders
Feeding and Eating Disorders - blood
Feeding and Eating Disorders - epidemiology
Feeding and Eating Disorders - physiopathology
Female
Humans
Japan
LDL cholesterol
Lipids - blood
Male
non-HDL cholesterol
Risk Factors
Young Adult
Title Serum Lipid Levels in Patients with Eating Disorders
URI https://www.jstage.jst.go.jp/article/internalmedicine/55/14/55_55.5632/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/27432092
https://www.proquest.com/docview/1805763014
https://www.proquest.com/docview/1837334210
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Internal Medicine, 2016/07/15, Vol.55(14), pp.1853-1857
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgIMQL4nOULwWJtykldpykfUSoU4G2INFK4ylybGcN3RK0Jg_w13NnO1mGOlR4iaI0lzR35_PP5_sg5A2NNGWKx36Eo4lrWKdkIyy5H3OhYT5kLMcd3fkinq74x5Oot9FuskvqbCh_7cwr-R-pwjWQK2bJ_oNku4fCBTgH-cIRJAzHvWQMA705P8L20-pohtE_Jrj1iy2V6vLWJsIENrdVNrd9NOrcgWfdDjvizWW1-Wn8pxgy2nMULMTGtq7-Vm3XmHdkW6bY-Nhzg0G_rhvs0FLIddHpRbNptoX9eV4ATXXpKyiLU2zFYsxTLS6avgeC9j0QzpVIMZPD2VFtDWnIx37CbCmS1tLagrytRvGe3UTU0JuDsUDVLvvOaIzlUQvHnZY5wygaRrHzk14pqb34nB6vZrN0OTlZ3iS3WJLYvfwPn9rpOhwlpnN29xE23Avf9Pa691zBMLe_A4w_1devUAxSWd4n99wSw3tn9eUBuaHLh-TO3D39EeFGbTyjNp5VG68ovVZtPFQbz6qN16nNY7I6nizfT33XPMOXccBrnzGtAavGMsiyTCQjkesQSzOZnnMRVWOesYSpRItcKslEwLkKc8AuSoKIsyx8Qg7KqtRPiRdJjVAqUFJynmtsQECVEkrIgCmW0wFJWnak0lWWxwYnZymsMJGR6Z-MTKMoRUYOCO0of9jqKnvQTC3HOwo3_nZSUG7oLGl3J2Y0ggEZkNetzFKwqrhVJkpdNduUjmAdE6O74W_3hEkYckaDATm0Au_-EgNgzoIxe7YH9XNy93JUvSAH9UWjXwLSrbNXRlN_A_xurTI
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+Lipid+Levels+in+Patients+with+Eating+Disorders&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=Nakai%2C+Yoshikatsu&rft.au=Noma%2C+Shun%27ichi&rft.au=Fukusima%2C+Mitsuo&rft.au=Taniguchi%2C+Ataru&rft.date=2016-01-01&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=55&rft.issue=14&rft.spage=1853&rft.epage=1857&rft_id=info:doi/10.2169%2Finternalmedicine.55.5632&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon